Prakt. lékáren. 2013; 9(2): 59-63

Local therapy of psoriasis

Zuzana Nevoralová
Kožní oddělení nemocnice v Jihlavě

Psoriasis is a chronic, inflammatory hyperproliferative disease of the skin, scalp, nails and joints. It belongs to a group of papulosquamosus

skin disorders and is presented by a variety of clinical presentations. Basic treatment is a local therapy, another treatment options

are phototherapy and systemic therapy. In this article, local therapy is described. It is a ground option for mild and moderate psoriasis,

a complementary one for a severy psoriasis. A first line local therapy includes topical corticosteroids and D3 derivates; tars, ichtamol,

cignolin, baths and local imunomodulators are also useful. Many completely new therapeutics are developed and proved.

Keywords: psoriasis, local therapy, corticosteroids, vitamin D3 derivates

Published: April 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nevoralová Z. Local therapy of psoriasis. Praktické lékárenství. 2013;9(2):59-63.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benáková N. Terapie obecně. In: Benáková N, Ettler K, Štork, J, Vašků V. Psoriáza nejen pro praxi. Praha/Kroměříž: Triton 2007: 59-69.
    2. Ettler K. Fototerapie. In: Benáková N, Ettler K, Štork J, Vašků V. Psoriáza nejen pro praxi. Praha/Kroměříž: Triton 2007: 102-112.
    3. Archier E, Devaux S, Castela E, et al. EfficacyofPsoralen UV-A therapy vs. Narrowband UV-B therapy in chronicplaque psoriasis: a systematicliteraturereview. J Eur AcadDermatolVenereol 2012; 26(Suppl.3): 11-21. Go to original source... Go to PubMed...
    4. Benáková N. Celková terapie. In: Benáková N: Terapie obecně. In: Benáková N, Ettler K, Štork J, Vašků V. Psoriáza nejen pro praxi. Praha/Kroměříž: Triton 2007: 117-131, 148-152.
    5. Pathriana D, Ormerod AD, Saiag P, et al. European S3-Guidelines on thesystemictreatmentof psoriasis. J Eur AcadDermatolVenereol 2009; 23(Suppl.2): 23, 27.
    6. Berend MAM, Sadek J, Kerkhof van de PCM, et al. Liver injury in long-term methotrexatetreatment in psoriasis isrelativelyinfrequent. DermatolTherapy 2006. Go to original source...
    7. Dostál C, Pavelka K, Saudek F, et al. Ciclosporinum. Remedia 2005; 1: 33-52.
    8. Benáková N, Štork J, et al. Léčba psoriázy biologiky. Konsenzuální doporučené postupy České dermatovenerologické společnosti ČLS JEP 2006. Čes-slov Derm 2006, 81(4): 1-11.
    9. Menter A, Korman NJ, Elmets CA, et al. Guidelinesofcarefor management of psoriasis and psoriasis arthritis. Section 6. Guidelinesofcarefor management of psoriasis and psoriasis arthritis: Case-basedpresentations and evidence-basedconclusions. J AmAcadDermatol 2011; 65: 134-174.
    10. Nast A, Boehncke WH, Mrowietz U, et al. S3-Guidelines on thetreatmentof psoriasis vulgaris. Update 2001. JDDG 2011; 9(Suppl.2): S1-S95. Go to original source...
    11. Cetkovská P, Kojanová M. Česká doporučení k biologické léčbě závažné chronické ložiskové psoriázy. Čes-slov Derm 2012, 87(1): I-XXII.
    12. Chiricozzi A, Chimenti S. EffectiveTopicalAgents and EmergingPerspectives in theTreatmentof Psoriasis. Expert RevDermatol 2012; 7(3): 283-293. Go to original source...
    13. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J. Immunol 2007; 178(5): 2623-2629. Go to original source... Go to PubMed...
    14. Subramaniam SV, Cooper RS, Adunyah SE. Evidence for the involvement of JAK/STAT pathway in the signaling mechanism of interleukin-17.BiochemBiophys Res Commun 1999; 262(1): 14-19. Go to original source... Go to PubMed...
    15. Kwatra SG, Dabade TS, Gustafson CJ, et al. JAK inhibitors in psoriasis: a promisingnewtreatment modality. J DrugsDermatol 2012; 11(8): 913-918.
    16. Psoriasis Treatment: What´s in the Future? www.webmd.com/skin.
    17. Papp KA, Gulliver W, Lynde CHW, et al. TheFutureof Psoriasis care. In: Papp KA, Gulliver W, Lynde CHW, et al. CanadianGuidelinesforthe Management ofPlaque Psoriasis. 2009; 1stedn: 89-92.
    18. Pánková R. Psychoterapie v ambulantní praxi. Lékařské listy 2003; 17: 14-16.
    19. Benáková N. Psoriáza v otázkách a odpovědích. Praha: Triton 2005: 128.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.